Availability, Prices and Affordability of Antibiotics Stocked by Informal Providers in Rural India: A Cross-Sectional Survey.
Availability, Prices and Affordability of Antibiotics Stocked by Informal Providers in Rural India: A Cross-Sectional Survey.
复制标题
DOI:
10.3390/antibiotics11040523
复制
发表时间:
2022-04-14
影响因子:
4.8
通讯作者:
Goodman, Catherine
中科院分区:
文献类型:
--
作者:
Gautham, Meenakshi;Miller, Rosalind;Rego, Sonia;Goodman, Catherine
关键词:
Providers without formal training deliver healthcare and antibiotics across rural India, but little is known about the antibiotics that they stock. We conducted a cross-sectional survey of such informal providers (IPs) in two districts of West Bengal, and assessed the availability of the antibiotics, as well as their sales volumes, retail prices, percentage markups for IPs and affordability. Of the 196 IPs that stocked antibiotics, 85% stocked tablets, 74% stocked syrups/suspensions/drops and 18% stocked injections. Across all the IPs, 42 antibiotic active ingredients were stocked, which comprised 278 branded generics from 74 manufacturers. The top five active ingredients that were stocked were amoxicillin potassium clavulanate (52% of the IPs), cefixime (39%), amoxicillin (33%), azithromycin (25%) and ciprofloxacin (21%). By the WHO’s AWaRe classification, 71% of the IPs stocked an ACCESS antibiotic and 84% stocked a WATCH antibiotic. The median prices were in line with the government ceiling prices, but with substantial variation between the lowest and highest priced brands. The most affordable among the top five tablets were ciprofloxacin, azithromycin, cefixime and amoxicillin (US$ 0.8, 0.9, 1.9 and 1.9 per course), and the most affordable among the syrups/suspensions/drops were azithromycin and ofloxacin (US$ 1.7 and 4.5 per course, respectively), which are mostly WATCH antibiotics. IPs are a key source of healthcare and antibiotics in rural communities; practical interventions that target IPs need to balance restricting WATCH antibiotics and expanding the basket of affordable ACCESS antibiotics.
登录
查看更多内容
影响因子:
168.9
作者:
Holmes, Alison H.;Moore, Luke S. P.;Piddock, Laura J. V.
通讯作者:
Piddock, Laura J. V.
DOI:
10.1016/j.socscimed.2021.113813
发表时间:
2021-04
期刊:
Social science & medicine (1982)
影响因子:
--
作者:
Gautham M;Spicer N;Chatterjee S;Goodman C
通讯作者:
Goodman C
影响因子:
8.1
作者:
Dasari M;David SD;Miller E;Puyana JC;Roy N
通讯作者:
Roy N
影响因子:
4.8
作者:
Khare, Shweta;Purohit, Manju;Pathak, Ashish
通讯作者:
Pathak, Ashish
DOI:
10.1016/s2214-109x(21)00024-3
发表时间:
2021-05
期刊:
The Lancet. Global health
影响因子:
--
作者:
Do NTT;Vu HTL;Nguyen CTK;Punpuing S;Khan WA;Gyapong M;Asante KP;Munguambe K;Gómez-Olivé FX;John-Langba J;Tran TK;Sunpuwan M;Sevene E;Nguyen HH;Ho PD;Matin MA;Ahmed S;Karim MM;Cambaco O;Afari-Asiedu S;Boamah-Kaali E;Abdulai MA;Williams J;Asiamah S;Amankwah G;Agyekum MP;Wagner F;Ariana P;Sigauque B;Tollman S;van Doorn HR;Sankoh O;Kinsman J;Wertheim HFL
通讯作者:
Wertheim HFL